If You Invested in Ardent Health, Inc. (ARDT)
Looking for the current price? See the ARDT quote & overviewWhat $1,000 or $10,000 in ARDT Would Be Worth Now
Real historical value by amount invested and how long ago| If you invested | 1 year ago | 5 years ago | 10 years ago | Since Jul 18, 2024 |
|---|---|---|---|---|
| $1,000 | $2,040 +104% | — | — | $1,105 +11% |
| $10,000 | $20,402 +104% | — | — | $11,052 +11% |
Based on real historical closing prices adjusted for stock splits, without dividends, through 2026-11-17. Figures with dividends reinvest each cash dividend at the previous close less the dividend, before taxes. Past performance does not guarantee future results.
Custom Calculation
Choose your own date and amount for ARDT$1,000 Investment Over Time
ARDT vs S&P 500Year-by-Year Returns
ARDT annual performance| Year | Start Price | End Price | Annual Return | Cumulative |
|---|---|---|---|---|
| 2024Jul 18 to Dec 31 | $16.06 | $17.08 | +6.4% | +6.4% |
| 2025 | $17.08 | $8.83 | -48.3% | -45.0% |
| 2026Dec 31, 2025 to Nov 17 | $8.83 | $17.75 | +101.0% | +10.5% |
About Ardent Health, Inc.
Healthcare · NYSE
Ardent Health, Inc. (NYSE: ARDT) is a healthcare company in the medical care facilities industry that focuses on delivering hospital and related services in growing mid-sized urban communities across the United States. The company describes itself as a provider of healthcare with a focus on people and on investments in services and technologies, with the goal of making healthcare better and easier to access.
According to its public disclosures, Ardent Health operates through subsidiaries that deliver care via a system of 30 acute care hospitals and approximately 280 sites of care across six states. These facilities are supported by more than 1,800 to 1,900 employed and affiliated providers, reflecting a networked approach to medical care facilities and related services. The company positions its operations around mid-sized urban communities, emphasizing growth markets rather than large metropolitan centers.
Business focus and care delivery footprint
Ardent Health’s business is centered on operating acute care hospitals and a broad set of additional sites of care. In its news releases, the company notes that it delivers care through hospitals and other facilities that together form its system of approximately 280 sites of care. These include locations that support inpatient and outpatient services, emergency room visits and surgeries, as reflected in the operating metrics the company reports in its quarterly results.
The company reports key operating statistics such as admissions, adjusted admissions, inpatient surgeries, outpatient surgeries, total surgeries and emergency room visits. It also tracks net patient service revenue per adjusted admission. These metrics are used in its quarterly press releases to describe trends in patient volumes and revenue performance and to explain the drivers of its financial results.
Financial reporting and non-GAAP metrics
In addition to reporting results under U.S. generally accepted accounting principles (GAAP), Ardent Health provides non-GAAP performance and valuation measures that it uses internally and shares with investors. In its quarterly results press releases, the company discusses Adjusted EBITDA, Adjusted EBITDA margin and Adjusted EBITDAR. It defines Adjusted EBITDA as net income plus provision for income taxes, interest expense and depreciation and amortization, adjusted for noncontrolling interest earnings and items such as loss on extinguishment and modification of debt, other non-operating gains or losses, certain restructuring, exit and acquisition-related costs, change in accounting estimate, specific professional liability accruals, expenses related to implementing its integrated health information technology system, equity-based compensation and income or loss from disposed operations.
Adjusted EBITDAR is defined by the company as Adjusted EBITDA further adjusted to add back rent expense payable to real estate investment trusts (REITs) under long-term lease arrangements and related transactions. Ardent Health explains in its disclosures that it operates 30 acute care hospitals, a portion of which are leased from REITs under master lease and other agreements. It notes that these lease arrangements and related medical office building transactions affect its capital structure and that adding back REIT rent in Adjusted EBITDAR is intended to allow comparisons with healthcare companies whose real estate portfolios are more heavily owned rather than leased.
The company states that these non-GAAP measures are used by management and external users of its financial statements, such as investors, analysts, lenders and rating agencies, to evaluate financial performance, allocate resources and assess enterprise value. It also emphasizes that these measures have limitations because they exclude necessary costs such as interest, taxes, depreciation, amortization and rent, and that they should not be considered in isolation or as substitutes for GAAP measures like net income.
Strategic and operational themes from disclosures
Ardent Health’s quarterly press releases highlight several recurring themes in its operations. The company reports on admissions growth, adjusted admissions growth, trends in inpatient and outpatient surgeries, and emergency room visits. It also discusses net patient service revenue per adjusted admission as a key indicator of revenue performance. In its commentary, the company has referenced factors such as demand trends, professional fee expense growth, payor denials and changes in accounting estimates related to the collectability of accounts receivable.
Ardent Health has described initiatives that it associates with operational efficiency and growth. In its communications, it has referred to a program it calls the IMPACT program, which includes actions such as workforce optimization and renegotiation of certain contracts, including with payors and agency labor. It has also mentioned focused initiatives in areas such as precision staffing, supply chain discipline and operating room (OR) excellence. In earlier quarters, the company noted the deployment of virtual nursing and AI-enabled scribe technologies, as well as efforts to advance an ambulatory growth strategy that involves urgent care centers and imaging care centers, and the integration of acquired urgent care assets.
The company has also described state-directed payment programs, such as those in New Mexico and Oklahoma, as part of its financial context. For example, it has mentioned the New Mexico state directed payment program (DPP) and its renewal, noting that such programs support providers in caring for Medicaid patients and that their financial contribution is reflected in its guidance assumptions.
Capital structure and credit facilities
Ardent Health’s SEC filings describe its credit arrangements and capital structure. In a Form 8-K dated September 18, 2025, the company reported entering into an amendment to its Amended and Restated Term Loan Credit Agreement and an amendment to its Amended and Restated ABL Credit Agreement. The term loan amendment refinanced outstanding term loans, extended the maturity date for the term loans from August 24, 2028 to September 18, 2032, reduced the applicable interest rate spreads over Term Secured Overnight Financing Rate (SOFR) and the base rate, and increased certain baskets for fixed dollar negative covenants. The ABL amendment updated certain covenant baskets to align with the term loan agreement but did not extend the maturity date or make other material changes.
The company’s quarterly press releases also summarize its balance sheet, cash flow and liquidity. They include information on total cash and cash equivalents, total debt, net leverage ratio under its credit agreements, lease-adjusted net leverage ratio and available liquidity. The company defines lease-adjusted net leverage ratio as net debt plus a multiple of trailing twelve-month REIT rent expense, divided by trailing twelve-month Adjusted EBITDAR, and notes that this measure is used in certain lease covenants.
Share repurchase authorization
In a Form 8-K dated November 17, 2025, Ardent Health reported that its board of directors authorized a stock repurchase program under which the company may repurchase up to $50.0 million of its common stock. The filing states that the program has no specified expiration date and that repurchases may be made through open market purchases, privately negotiated transactions, block trades or other transactions in accordance with applicable securities laws, subject to market conditions and other factors. The company noted that it may enter into Rule 10b5-1 plans to facilitate repurchases, that the program does not obligate it to acquire any specific amount of stock and that it may be modified, suspended or terminated at any time. The company indicated that it expects to fund repurchases with existing cash and cash equivalents and ongoing cash from operations.
Corporate name and listing
Ardent Health is listed on the New York Stock Exchange under the ticker symbol ARDT. In a Business Wire release dated May 23, 2025, the company announced that its board of directors voted to change its name from Ardent Health Partners, Inc. to Ardent Health, Inc., effective June 3, 2025. The company stated that the name change was intended to align its legal name with the way it refers to itself in communications and to support a consistent brand identity. It also stated that the name change would not affect its trading symbol on the NYSE, its CUSIP number or the rights of its stockholders.
Management and governance developments
In a Form 8-K dated June 16, 2025, Ardent Health reported a change in its leadership team. The filing stated that David Schultz would no longer serve as President, Hospital Operations and would depart the company effective immediately. The company treated his departure as a qualifying termination under its Executive Severance Plan, entitling him to severance and related benefits subject to the plan’s terms and conditions.
In a separate Business Wire release dated May 19, 2025, Ardent Health announced the appointment of a chief development officer. The company stated that this role would lead development efforts across existing markets and support expansion into new regions, with responsibilities that include driving growth across inpatient and outpatient care settings through acquisitions, partnerships and joint ventures, as well as guiding due diligence, market intelligence and integration planning.
Investor communications and guidance
Ardent Health regularly issues press releases announcing its quarterly financial results and schedules conference calls and webcasts to discuss those results. These communications include financial guidance for the full year, such as ranges for total revenue, net income attributable to Ardent Health, Adjusted EBITDA, rent expense payable to REITs, diluted earnings per share, adjusted admissions growth, net patient service revenue per adjusted admission growth and capital expenditures. The company notes that its guidance is based on current plans and expectations and is subject to risks and uncertainties, and it presents forward-looking statements language in its releases.
The company also participates in healthcare and investor conferences, where members of its management team take part in fireside chats and one-on-one meetings with investors. It provides access to live audio webcasts of these events and of its earnings calls, as described in its news releases.
Similar Stocks
See how related companies performed
Frequently Asked Questions
Ardent Health, Inc. investment returns
How much would $1,000 invested in Ardent Health, Inc. be worth today?
If you invested $1,000 in Ardent Health, Inc. (ARDT) 1 year ago on 2025-11-18, your investment would be worth $2,040 as of 2026-11-17, a +104.0% price return without dividends.
Has Ardent Health, Inc. outperformed the S&P 500?
Comparison data requires at least 10 years of trading history. Use the calculator above to compare ARDT performance over available time periods.
What is Ardent Health, Inc.'s average annual return?
Over the past 1 year, ARDT’s share price returned +104.0%, without dividends. Individual years vary a great deal, and ARDT’s best recent full year was 2025 (-48.3%) while the worst was 2025 (-48.3%).
For informational and educational purposes only, not investment advice.